Raghu Rao

Parallel DeepTech Entrepreneur, Investor & Fund Partner, Strategic Advisor and NACD CERT Certified Board Director

📍 Princeton, New Jersey, United States🔄 Updated September 2026💼 8 investments📅 18 years investing🗓 Last invested Oct 2020𝕏 @upgrade_to_unlock
VC🌍 United States
8
Total investments
1
Early stage
0
Mid stage
1
Late stage
18y
Years active

Portfolio

3 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Strategic Advisor & Investor
Oct 2020
MultiomeDx is focused on Women’s Health Diagnostics. We are providing Point-of-Care solution for various unmet needs in women’s Diagnostics. Our first product is a rule out test for Pre-eclampsia. We are also focused on deploying our point of care tests to hard to reach areas in India for cervical cancer screening. Since the platform, POC device is sensitive, accurate and cost effective, it is a great fit for deploying in a mobile van to hard to reach areas. The same platform can also test for other tropical diseases such as Dengue and Chikungunya.
Strategic Advisor and Investor
Dec 2019
Globavir Biosciences is a San Francisco Bay Area based company committed to the development of therapeutics and diagnostics for the treatment of global infectious diseases. Globavir's development strategy harnesses the advantages offered by the 505(b)2 regulatory pathway, allowing for rapid development of new therapies. Globavir is initially focused on the treatment of dengue virus infection, a potentially lethal disease infecting 390 million patients annually. Through the combination of our proprietary diagnostic technology and advanced therapeutic candidates, Globavir is ideally positioned to rapidly impact the clinical landscape for Dengue patients. Globavir's platform discovery technologies have further identified candidate compounds with efficacy in additional viral indications, including West Nile, Japanese Encephalitis, Ebola, Marburg, and Hunta viruses.
Board Member / Founding Investor
Jun 2010
WizNucleus provides cyber & physical security solutions for mission-critical facilities, including nuclear and electric.
Experience · 19 entries
All (19)
Investments (8)
Founder (5)
Board (3)
2024
Founding Partner
Sep 2024
Maatra is a global quantitative investment firm harnessing cutting edge technology and data to generate true alpha. Our innovative strategies leverage Artificial Intelligence to uncover market opportunities and deliver superior risk adjusted returns
2023
Equity and Operating Partner (Non-Executive)
Sep 2023
In todays challenging economy, businesses face rising costs that can hinder growth and sustainability. But what if you could access specialized savings programs that could lower insurance, office supply, healthcare, and energy costs? What if your accounts payable department could generate income, and your hourly employees could access earned wages instantly? Plus, what if you could stay informed about nationwide class action filings and recover overcharges? And, what if you could take advantage of government tax incentive programs at the state and federal levels, as well as other expense reduction opportunities in areas like copier and printer costs, credit card processing, parcel shipping, waste and recycle wireless service, and even workers compensation - without having to switch service providers
2022
Entrepreneur In Residence
Apr 2022
At Bridge Point Capital, were entrepreneurs and operators just like you. We focus on connecting like-minded investors with opportunities to invest in exciting and cutting-edge innovation that is changing the world while creating vast wealth. Our fellow investors are interested in growing and preserving their wealth while making a positive impact.
2020
Strategic Advisor & Investor
Oct 2020
MultiomeDx is focused on Women’s Health Diagnostics. We are providing Point-of-Care solution for various unmet needs in women’s Diagnostics. Our first product is a rule out test for Pre-eclampsia. We are also focused on deploying our point of care tests to hard to reach areas in India for cervical cancer screening. Since the platform, POC device is sensitive, accurate and cost effective, it is a great fit for deploying in a mobile van to hard to reach areas. The same platform can also test for other tropical diseases such as Dengue and Chikungunya.
Principal and Strategic Advisor
Apr 2020
Splitbyte secures corporate information and delivers it only to the intended party. Splitting the data into pieces and then geo-dispersing it, allows a higher level of data protection. Threshold cryptography allows redundancy and fault-tolerant data retrieval while eliminating the vulnerabilities and complexities of traditional key-management.
Show all 19 entries ↓
Investment activity
2008–2020 · 8 investments
20081200912010220151201612019120201
Recent (last 2 years)Earlier